Search research articles
Contact Us
Filters
Showing results (91-100 of 223) with videos related to
Page
of 23
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 25, 2012
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells
Rosalba Minelli, Roberta Cavalli, Leigh Ellis, et al.
Plos One
|
August 30, 2023
A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors
Steen Knudsen, Anker Hansen, Marie Foegh, et al.
Photochemistry and Photobiology
|
June 23, 2026
Single-treatment in situ photo-vaccination with paclitaxel prodrug-PDT enables durable local and abscopal tumor control in a bilateral Colon 26 model
Kazi Md Mahabubur Rahman, Sheryl Dsouza, Soniya Kumbham, et al.
PLOS Digital Health
|
May 5, 2026
Identifying factors associated with vaping cessation in young adults: A machine learning and XAI approach
Poolakkad S Satheeshkumar, Ian Lango, Swarnali Zafo, et al.
PLOS Mental Health
|
February 9, 2026
Impact of mental health on burden of illness, septicemia and mortality among patients hospitalized for cancer
Poolakkad S Satheeshkumar, Roberto Pili, Sudheer B Kurunthatil Thazhe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors
Henk M W Verheul, Brenda Salumbides, Karen Van Erp, et al.
Cancer Research
|
March 25, 2018
Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
Remi Adelaiye-Ogala, Nur P Damayanti, Ashley R Orillion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
David Z Qian, Yukihiko Kato, Shabana Shabbeer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2010
Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study
Daniel Keizman, Marianna Zahurak, Victoria Sinibaldi, et al.
Molecular Cancer Therapeutics
|
November 9, 2014
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models
Eric Ciamporcero, Kiersten Marie Miles, Remi Adelaiye, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 223) with videos related to
Sort By:
Page
of 23
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
August 25, 2012
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells
Rosalba Minelli, Roberta Cavalli, Leigh Ellis, et al.
Plos One
|
August 30, 2023
A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors
Steen Knudsen, Anker Hansen, Marie Foegh, et al.
Photochemistry and Photobiology
|
June 23, 2026
Single-treatment in situ photo-vaccination with paclitaxel prodrug-PDT enables durable local and abscopal tumor control in a bilateral Colon 26 model
Kazi Md Mahabubur Rahman, Sheryl Dsouza, Soniya Kumbham, et al.
PLOS Digital Health
|
May 5, 2026
Identifying factors associated with vaping cessation in young adults: A machine learning and XAI approach
Poolakkad S Satheeshkumar, Ian Lango, Swarnali Zafo, et al.
PLOS Mental Health
|
February 9, 2026
Impact of mental health on burden of illness, septicemia and mortality among patients hospitalized for cancer
Poolakkad S Satheeshkumar, Roberto Pili, Sudheer B Kurunthatil Thazhe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors
Henk M W Verheul, Brenda Salumbides, Karen Van Erp, et al.
Cancer Research
|
March 25, 2018
Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
Remi Adelaiye-Ogala, Nur P Damayanti, Ashley R Orillion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
David Z Qian, Yukihiko Kato, Shabana Shabbeer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2010
Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: results of a phase I/II double-blinded, randomized study
Daniel Keizman, Marianna Zahurak, Victoria Sinibaldi, et al.
Molecular Cancer Therapeutics
|
November 9, 2014
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models
Eric Ciamporcero, Kiersten Marie Miles, Remi Adelaiye, et al.
Page
of 23